Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.
about
A review on segmentation of positron emission tomography imagesMotion freeze for respiration motion correction in PET/CT: a preliminary investigation with lung cancer patient data.Application of machine learning methodology for PET-based definition of lung cancer.Prognostic Value of Metabolic Tumor Volume Measured by (18)F-FDG PET/CT in Locally Advanced Head and Neck Squamous Cell Carcinomas Treated by Surgery.Simultaneous Tumor Segmentation, Image Restoration, and Blur Kernel Estimation in PET Using Multiple RegularizationsAdaptive region-growing with maximum curvature strategy for tumor segmentation in 18F-FDG PET.18F-FDG PET/CT of Non-Small Cell Lung Carcinoma Under Neoadjuvant Chemotherapy: Background-Based Adaptive-Volume Metrics Outperform TLG and MTV in Predicting Histopathologic ResponseBroadening the scope of image-guided radiotherapy (IGRT).The impact of respiratory motion on tumor quantification and delineation in static PET/CT imaging18F-FDG PET/CT for image-guided and intensity-modulated radiotherapy.Computational modeling of cancer cachexia.A fuzzy locally adaptive Bayesian segmentation approach for volume determination in PET.18F-FDG PET/CT-based gross tumor volume definition for radiotherapy in head and neck cancer: a correlation study between suitable uptake value threshold and tumor parameters.Correlation of (18)F-FDG avid volumes on pre-radiation therapy and post-radiation therapy FDG PET scans in recurrent lung cancer.Segmentation of PET images for computer-aided functional quantification of tuberculosis in small animal models.Volumetric CT-based segmentation of NSCLC using 3D-SlicerPositron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapyFunctional and molecular image guidance in radiotherapy treatment planning optimization.Optimal gating compared to 3D and 4D PET reconstruction for characterization of lung tumours.Radiobiological Modeling Based on (18)F-Fluorodeoxyglucose Positron Emission Tomography Data for Esophageal Cancer.Determination of an optimal standardized uptake value of fluorodeoxyglucose for positron emission tomography imaging to assess pathological volumes of cervical cancer: a prospective studyCan FDG PET predict radiation treatment outcome in head and neck cancer? Results of a prospective study.Tumor vascularity and glucose metabolism correlated in adenocarcinoma, but not in squamous cell carcinoma of the lungEvaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studiesImpact of [¹⁸F]FDG PET imaging parameters on automatic tumour delineation: need for improved tumour delineation methodology.The association of tumor-to-background ratios and SUVmax deviations related to point spread function and time-of-flight F18-FDG-PET/CT reconstruction in colorectal liver metastases.Noninvasive Evaluation of Metabolic Tumor Volume in Lewis Lung Carcinoma Tumor-Bearing C57BL/6 Mice with Micro-PET and the Radiotracers 18F-Alfatide and 18F-FDG: A Comparative Analysis.18F-FDG PET-Derived Textural Indices Reflect Tissue-Specific Uptake Pattern in Non-Small Cell Lung Cancer.Comparative methods for PET image segmentation in pharyngolaryngeal squamous cell carcinoma.Respiration-Averaged CT for Attenuation Correction of PET Images - Impact on PET Texture Features in Non-Small Cell Lung Cancer PatientsDose distribution and tumor control probability in out-of-field lymph node stations in intensity modulated radiotherapy (IMRT) vs 3D-conformal radiotherapy (3D-CRT) of non-small-cell lung cancer: an in silico analysis.Predicting outcomes in radiation oncology--multifactorial decision support systemsAssessment of Lymph Nodes and Prostate Status Using Early Dynamic Curves with (18)F-Choline PET/CT in Prostate CancerOptimal definition of biological tumor volume using positron emission tomography in an animal model.Delineation of FDG-PET tumors from heterogeneous background using spectral clusteringPre-Chemoradiotherapy FDG PET/CT cannot Identify Residual Metabolically-Active Volumes within Individual Esophageal TumorsAssociations between the standardized uptake value of (18)F-FDG PET/CT and demographic, clinical, pathological, radiological factors in lung cancer.The physical basis and future of radiation therapy.Conventional 3D staging PET/CT in CT simulation for lung cancer: impact of rigid and deformable target volume alignments for radiotherapy treatment planningImpact of tumor size and tracer uptake heterogeneity in (18)F-FDG PET and CT non-small cell lung cancer tumor delineation
P2860
Q26825470-94A8724F-3AE1-4D41-ADE3-9C57D3453613Q30854818-D8587AB4-BC9D-4114-97B0-54F0F1C1F8FAQ33680357-EA3BABD2-7D30-4FC2-980C-069BEBECADD8Q33704148-7059B6F0-FEC3-4885-8ED6-2F826C7E7236Q33777233-5B34C000-A150-466C-8708-10EC11C8EFA2Q33873255-782A41C1-195D-49C1-9A7E-D6AB5607397AQ33904549-AF6FC43E-3136-44F3-B05E-5027EF52C0AEQ33943514-E50FFFE6-0674-424B-9478-83D450AF9B97Q33955314-86CD3C6E-B7CE-4DF2-8FB9-65065D1E7DB5Q33973367-0F37474C-25F2-4A6E-B4DC-1A1BB0987361Q34011017-6858E278-58F7-405F-9BB4-365B6A3692CFQ34031659-05B45EA9-7333-41D9-9805-57C64B73A57BQ34142516-81575381-5B66-451A-A0F2-14AC904E5F30Q34206480-D9DF19FD-09ED-4390-A4FB-1098BFA1E69BQ34337141-D1F9818B-F3C4-4BF1-A2BC-120AD6FE4154Q34392512-E03AD9AB-D47C-49EC-BED8-57AD62A6DFA8Q34517660-0F6169D0-1930-492E-8ED1-814235EAD683Q34706820-F0D5CC88-94F0-4129-9A56-4AD57D4C9979Q34756997-778CE1D5-765C-4845-BE84-4B6CC94190E5Q34858176-41A2EFF6-6C68-437F-9EEF-A79A38609766Q35050244-747BB746-B745-44BB-A509-5428351F55E9Q35078927-4A2024FA-E0AD-44AB-82B7-42516698C497Q35116157-BE36DD93-D14B-4E9A-91DD-BE0677118F1CQ35151263-A5C52DCE-9AAA-4604-88D9-7C6AC1E487AFQ35586008-281D4493-B9FB-4DFF-881A-F72A255422C7Q35593955-4F77D1DB-3543-4F56-9967-CF89DFADFFD2Q35767740-DBD98730-3389-47AB-BCAB-069C1A1F92ADQ35869109-5053B9E9-8C2A-4825-BB00-61BE58F5B543Q35888593-4EBCE0EF-EDB8-4188-9E32-F21004D7C2B8Q35940876-048921B6-59B9-4C94-8F16-127A428F4C98Q36010155-83989825-7B9A-42E4-9903-F73F66AD0ACFQ36014711-C5E87F95-49F6-40FE-AABA-F3A427558B47Q36039090-2B51271B-1B07-4880-8DB1-FBB6E6E62B50Q36192160-C179D4EF-A922-47EF-8106-B7988CA0CECCQ36295954-D27C8295-D0DE-4801-A0A9-7A534ED7DD0AQ36299550-3AE223A7-29FB-4273-85FA-CB51516527A5Q36317680-C96D4435-39CB-429A-949B-078B8B2EDEE2Q36324594-B0DE87FC-956E-4E5A-8287-4D744210AEA1Q36324961-1A81600B-EA40-4964-9D71-1749604FF349Q36350466-3CF75ACC-7C72-4C48-85C4-42B7C4F6734D
P2860
Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Comparison of different method ...... th non-Small cell lung cancer.
@en
Comparison of different method ...... th non-Small cell lung cancer.
@nl
type
label
Comparison of different method ...... th non-Small cell lung cancer.
@en
Comparison of different method ...... th non-Small cell lung cancer.
@nl
prefLabel
Comparison of different method ...... th non-Small cell lung cancer.
@en
Comparison of different method ...... th non-Small cell lung cancer.
@nl
P2093
P1476
Comparison of different method ...... ith non-Small cell lung cancer
@en
P2093
Andrea Schaefer-Schuler
Carl-Martin Kirsch
Christian Rübe
Christiane Sebastian-Welsch
Dirk Hellwig
Stephanie Kremp
Ursula Nestle
P304
P407
P577
2005-08-01T00:00:00Z